- Johnson & Johnson (NYSE:JNJ) said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move amid continued legal battles and two years after the company .
- After assessing its portfolio, J&J said it had made the "commercial decision" to transition all its baby powder products to cornstarch instead of talcum powder in 2023.
- Related: .
- The health conglomerate maintains that the product is safe. It faces about 38,000 lawsuits claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.
- Last year, J&J created a subsidiary, LTL Management, , and put the company into bankruptcy, pausing the legal actions.
- Also Read:
- Before the bankruptcy filing, the company faced costs from $3.5 billion in verdicts and settlements, including one in which 22 women were awarded a judgment.
- Price Action: JNJ shares are up 0.48% at $167.94 during the premarket session on the last check Friday.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.